AAAAAA
Results:
1-14
|
Results: 14
Authors:
Arevalo, I
Ward, B
Miller, R
Meng, TC
Najar, E
Alvarez, E
Matlashewski, G
Llanos-Cuentas, A
Citation: I. Arevalo et al., Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator, CLIN INF D, 33(11), 2001, pp. 1847-1851
Authors:
Zhang, WW
Matlashewski, G
Citation: Ww. Zhang et G. Matlashewski, Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection, MOL MICROB, 39(4), 2001, pp. 935-948
Authors:
Matlashewski, G
Citation: G. Matlashewski, Leishmania infection and virulence, MED MICROBI, 190(1-2), 2001, pp. 37-42
Authors:
Ghosh, A
Zhang, WW
Matlashewski, G
Citation: A. Ghosh et al., Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections, VACCINE, 20(1-2), 2001, pp. 59-66
Authors:
Ghosh, A
Labrecque, S
Matlashewski, G
Citation: A. Ghosh et al., Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response, VACCINE, 19(23-24), 2001, pp. 3169-3178
Authors:
Buates, S
Matlashewski, G
Citation: S. Buates et G. Matlashewski, Identification of genes induced by a macrophage activator, S-28463, using gene expression array analysis, ANTIM AG CH, 45(4), 2001, pp. 1137-1142
Authors:
Moisan, J
Wojciechowski, W
Guilbault, C
Lachance, C
Di Marco, S
Skamene, E
Matlashewski, G
Radzioch, D
Citation: J. Moisan et al., Clearance of infection with Mycobacterium bovis BCG in mice is enhanced bytreatment with S28463 (R-848), and its efficiency depends on expression ofwild-type Nramp1 (resistance allele), ANTIM AG CH, 45(11), 2001, pp. 3059-3064
Authors:
Buates, S
Matlashewski, G
Citation: S. Buates et G. Matlashewski, General suppression of macrophage gene expression during Leishmania donovani infection, J IMMUNOL, 166(5), 2001, pp. 3416-3422
Authors:
Zhang, WW
Labrecque, S
Azoulay, E
Dudley, R
Matlashewski, G
Citation: Ww. Zhang et al., Development of a p53 responsive GFP reporter; identification of live cellswith p53 activity, J BIOTECH, 84(1), 2000, pp. 79-86
Authors:
Zhang, WW
Matlashewski, G
Citation: Ww. Zhang et G. Matlashewski, Analysis of antisense and double stranded RNA downregulation of A2 proteinexpression in Leishmania donovani, MOL BIOCH P, 107(2), 2000, pp. 315-319
Authors:
Makni, H
Franco, EL
Kaiano, J
Villa, LL
Labrecque, S
Dudley, R
Storey, A
Matlashewski, G
Citation: H. Makni et al., p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation, INT J CANC, 87(4), 2000, pp. 528-533
Authors:
Thomas, M
Kalita, A
Labrecque, S
Pim, D
Banks, L
Matlashewski, G
Citation: M. Thomas et al., Two polymorphic variants of wild-type p53 differ biochemically and biologically, MOL CELL B, 19(2), 1999, pp. 1092-1100
Authors:
Buates, S
Matlashewski, G
Citation: S. Buates et G. Matlashewski, Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: Efficacy and mode of action, J INFEC DIS, 179(6), 1999, pp. 1485-1494
Authors:
Storey, A
Thomas, M
Kalita, A
Harwood, C
Gardiol, D
Mantovani, F
Breuer, J
Leigh, IM
Matlashewski, G
Banks, L
Citation: A. Storey et al., p53 polymorphism and risk of cervical cancer - Reply, NATURE, 396(6711), 1998, pp. 532-532
Risultati:
1-14
|